SciSparc Ltd (SPRC)

NASDAQ

$4.70

SciSparc Ltd., a specialized clinical-stage pharmaceutical company, develops drugs based on cannabinoid molecules. The company is headquartered in Tel Aviv, Israel.

Website: https://scisparc.com

Sector:

Healthcare

Industry:

Biotechnology

Market Cap

$3.05M

P/E Ratio

0.00

Beta (5Y)

1.27

Price Chart

Adjust inflation

Log

Valuation

Market Cap$3.05M

P/E0.00

P/S2.33

P/B1.19

Profitability

Total Revenue (TTM)$1.31M

Gross Profit (TTM)$631K

EBITDA-$7.03M

Operating Margin-570%

EPS$350.73

Growth & Risk

Beta (5Y)1.27

Sharpe Ratio-0.25